A detailed history of Y Intercept (Hong Kong) LTD transactions in Pfizer Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 36,233 shares of PFE stock, worth $955,101. This represents 0.07% of its overall portfolio holdings.

Number of Shares
36,233
Previous 120,939 70.04%
Holding current value
$955,101
Previous $3.38 Million 69.02%
% of portfolio
0.07%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$27.7 - $31.39 $2.35 Million - $2.66 Million
-84,706 Reduced 70.04%
36,233 $1.05 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $2.57 Million - $3.01 Million
101,654 Added 527.11%
120,939 $3.38 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $499,288 - $573,343
19,285 New
19,285 $535,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $1.28 Million - $1.48 Million
-35,466 Reduced 81.47%
8,067 $295,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $563,631 - $733,765
-14,309 Reduced 24.74%
43,533 $1.78 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $689,668 - $900,285
16,519 Added 39.98%
57,842 $2.96 Million
Q3 2022

Feb 14, 2023

BUY
$43.76 - $53.42 $1.81 Million - $2.21 Million
41,323 New
41,323 $1.81 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $3.39 Million - $5.03 Million
-82,065 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $2.45 Million - $3.15 Million
62,522 Added 319.92%
82,065 $3.53 Million
Q2 2021

Aug 26, 2021

BUY
$35.91 - $40.68 $701,789 - $795,009
19,543 New
19,543 $765,000
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $284,550 - $322,348
-7,924 Closed
0 $765,000
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $953,158 - $1.07 Million
-28,461 Reduced 78.22%
7,924 $286,000
Q4 2020

Feb 05, 2021

BUY
$33.47 - $42.56 $1.22 Million - $1.55 Million
36,385 New
36,385 $1.34 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.